OPA1 in Cardiovascular Health and Disease

被引：18
|
作者：
Burke, Niall [1 ]
Hall, Andrew R. [1 ]
Hausenloy, Derek J. [1 ,2 ,3 ]
机构：
[1] UCL, Hatter Cardiovasc Inst, 67 Chenies Mews, London WC1E 6HX, England
[2] Duke NUS Grad Med Sch, Cardiovasc & Metab Disorders Program, Singapore, Singapore
[3] Natl Heart Ctr, Natl Heart Res Inst Singapore, Singapore, Singapore
来源：
CURRENT DRUG TARGETS | 2015年 / 16卷 / 08期
基金：
英国医学研究理事会;
关键词：
Cardiovascular disease; fission; fusion; mitochondrial morphology; OPA1; DOMINANT OPTIC ATROPHY; CYTOCHROME-C RELEASE; MITOCHONDRIAL PROTEASE OMA1; DYNAMIN-RELATED PROTEIN; PROTEOLYTIC CLEAVAGE; OXIDATIVE-PHOSPHORYLATION; RESPIRATORY-CHAIN; GTPASE OPA1; FUSION; MORPHOLOGY;
D O I：
10.2174/1389450116666150102113648
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Mitochondria are known to play crucial roles in normal cellular physiology and in more recent years they have been implicated in a wide range of pathologies. Central to both these roles is their ability to alter their shape interchangeably between two different morphologies: an elongated interconnected network and a fragmented discrete phenotype - processes which are under the regulation of the mitochondrial fusion and fission proteins, respectively. In this review article, we focus on the mitochondrial fusion protein optic atrophy protein 1 (OPA1) in cardiovascular health and disease and we explore its role as a potential therapeutic target for treating cardiovascular and metabolic disease.
引用
收藏
页码：912 / 920
页数：9
相关论文
共 50 条
  • [41] Inner retinal degeneration in Opa1 haploinsufficient mouse
    Votruba, Marcela
    Seto, Sharon
    Erchova, Irina
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [42] Oxidation of the mitochondrial fusion protein OPA1 in the heart
    Semenzato, M.
    Frezza, C.
    Carpi, A.
    Dilisa, F.
    Scorrano, L.
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2008, 44 (04) : 785 - 785
  • [43] Mutation spectrum and splicing variants in the OPA1 gene
    Delettre, C
    Griffoin, JM
    Kaplan, J
    Dollfus, H
    Lorenz, B
    Faivre, L
    Lenaers, G
    Belenguer, P
    Hamel, CP
    HUMAN GENETICS, 2001, 109 (06) : 584 - 591
  • [44] eOPA1:: An online database for OPA1 mutations
    Ferré, M
    Amati-Bonneau, P
    Tourmen, Y
    Malthièry, Y
    Reynier, P
    HUMAN MUTATION, 2005, 25 (05) : 423 - 428
  • [45] OPA1 disease-causing mutants perturb mitochondrial nucleoid cluster distribution
    Eisner, Veronica
    Macuada, Josefa
    Vidal, Gonzalo
    Molina-Riquelme, Isidora
    Aedo, Geraldine
    Lagos, Daniel
    Perez, Nicolas
    Rudge, Timothy
    Cartes-Saavedra, Benjamin
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS, 2022, 1863 : 84 - 85
  • [46] Mitochondrial disorder with OPA1 mutation and no optic atrophy
    Milone, M.
    Younge, B.
    Wang, J.
    Zhang, S.
    Wong, L-J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 : 204 - 204
  • [47] OPA1, a new mitochondrial target in cancer therapy
    Herkenne, Stephanie
    Scorrano, Luca
    AGING-US, 2020, 12 (21): : 20931 - 20933
  • [48] 'Behr syndrome' with OPA1 compound heterozygote mutations
    Carelli, Valerio
    Sabatelli, Mario
    Carrozzo, Rosalba
    Rizza, Teresa
    Schimpf, Simone
    Wissinger, Bernd
    Zanna, Claudia
    Rugolo, Michela
    La Morgia, Chiara
    Caporali, Leonardo
    Carbonelli, Michele
    Barboni, Piero
    Tonon, Caterina
    Lodi, Raffaele
    Bertini, Enrico
    BRAIN, 2015, 138
  • [49] OPA1 and cardiolipin team up for mitochondrial fusion
    Raymond Liu
    David C. Chan
    Nature Cell Biology, 2017, 19 : 760 - 762
  • [50] SUBCLINICAL MULTISYSTEM NEUROLOGIC DISEASE IN "PURE" OPA1 AUTOSOMAL DOMINANT OPTIC ATROPHY
    Baker, M. R.
    Fisher, K. M.
    Whittaker, R. G.
    Griffiths, P. G.
    Yu-Wai-Man, P.
    Chinnery, P. F.
    NEUROLOGY, 2011, 77 (13) : 1309 - 1312
12345